These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 9015795

  • 1. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 2. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
    Seeman P, Corbett R, Nam D, Van Tol HH.
    Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201
    [Abstract] [Full Text] [Related]

  • 3. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P, Tallerico T.
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic receptor-blocking concentrations of neuroleptics.
    Seeman P.
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():5-13. PubMed ID: 8866760
    [Abstract] [Full Text] [Related]

  • 5. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
    Seeman P, Van Tol HH.
    Eur J Pharmacol; 1995 Oct 15; 291(2):59-66. PubMed ID: 8566176
    [Abstract] [Full Text] [Related]

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 15; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI, Yeghiayan SK, Baldessarini RJ, Kula NS, Neumeyer JL.
    Neuropsychopharmacology; 1997 Sep 15; 17(3):186-96. PubMed ID: 9272485
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P.
    Neuropsychopharmacology; 1992 Dec 15; 7(4):261-84. PubMed ID: 1362057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY.
    Clin Neurosci; 1995 Dec 15; 3(2):64-75. PubMed ID: 7583621
    [Abstract] [Full Text] [Related]

  • 15. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE, Janssen PM, Megens AA, Schotte A.
    J Clin Psychiatry; 1994 May 15; 55 Suppl():5-12. PubMed ID: 7520908
    [Abstract] [Full Text] [Related]

  • 16. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
    Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY.
    Psychopharmacology (Berl); 1995 Aug 15; 120(3):365-8. PubMed ID: 8524985
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 18. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun 15; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 19. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 15; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
    Kapur S, Seeman P.
    J Psychiatry Neurosci; 2000 Mar 15; 25(2):161-6. PubMed ID: 10740989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.